Division of Terumo Corporation (TSE:4543), a global healthcare technology leader since 1921 with 30,000+ employees. Provides sterile injectable contract development and manufacturing (CDMO) services from combination device design and formulation development to commercial manufacturing. Offers a portfolio of injection, infusion, and primary packaging solutions including PLAJEX polymer pre-fillable syringes, Immucise intradermal injection systems, hypodermic needles, and Surflo winged infusion sets. Recently expanded CDMO services outside Japan for global market and is doubling capacity.
Sterile injectable CDMO services, pre-fillable polymer syringe systems (PLAJEX), combination product design and development, intradermal injection (Immucise), materials and compatibility analysis, downstream manufacturing optimization, global regulatory data and filing guidance, primary packaging solutions.
1 site worldwide
No reviews available yet.
No documents available.